JEANETTE PIRKLE: Open Payments
NPI 1033459482 · GAINESVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,480 in 146 payments from 44 companies in 2025. Trend: 2023 $2,916 · 2024 $4,534 · 2025 $3,480
Food & beverage: $3,219Education: $261
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $359 |
| Novartis Pharmaceuticals Corporation | 11 | $220 |
| Astellas Pharma US Inc | 3 | $207 |
| PFIZER INC. | 8 | $193 |
| Merck Sharp & Dohme LLC | 6 | $171 |
| Janssen Biotech, Inc. | 7 | $164 |
| ABBVIE INC. | 9 | $163 |
| GENZYME CORPORATION | 5 | $156 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $141 |
| Genentech USA, Inc. | 8 | $139 |
Products named: SARCLISA, Enhertu, KEYTRUDA, TAGRISSO, Nubeqa, EPKINLY, REBLOZYL, FRUZAQLA.
Industry payments across GA — which companies pay providers there.
